argenx – Gent, Belgium

510.9FTEEmployeesVerifiedas of 31 Dec 2025

2009FoundedVerified

5/5Financial years checkedFY 2021 – FY 2025

—Average ratingNo reviews yet

0AwardsNo published awards yet

01Overview

About argenx

Short description by MeritVeri

argenx is an immunology biotech founded in 2008 in Ghent that develops antibody-based medicines for severe autoimmune diseases. Its approved product efgartigimod (VYVGART and VYVGART Hytrulo) treats generalized myasthenia gravis and CIDP, and it has further candidates in its pipeline. Its Belgian office is at Industriepark Zwijnaarde.

On this profile

02VerificationVerified8 items checked by MeritVeri
03FinancialsProfit in 2 of 5 years · FY 2021 – FY 2025
04People3 board members, named
06AwardsNo published awards yet
07ReviewsNo reviews yet

02Verification

Checked fact by fact

MeritVeri checks each fact against official public sources, the company's own publications or documentary evidence, and lists exactly what was checked. Nothing on this list can be bought.

Verified

Verified on 19 October 2026, valid until the end of 19 October 2027 (Brussels time).

VRF-BE-2026-000131

Official public sourcesBusiness register, central balance sheet office, official gazette, EU VAT system and LEI record
Published by the companyThe company's own published annual reports and website
Decided by MeritVeriMeritVeri decides every verification and records it with its date and reference

What was checked8 items

Items checked by MeritVeri, with the checked value, the source and the state of each
Item	Checked value	Source	State
Registration number	0818.292.196	—	Verified
VAT number	BE 0818.292.196	—	Verified
Registered office address	Industriepark-Zwijnaarde 7, 9052 Gent	—	Verified
Website	https://argenx.com/	—	Verified
Year founded	2009	—	Verified
Number of employees	510.9 FTEas of 31 Dec 2025	—	Verified
Board of directors	3 directorssee People	—	Verified
Financial statements	FY 2021 – FY 2025 · 5 yearssee Financials	—	Verified

All items checked on 19 Oct 2026

Outside this verification

Quality of products and services
Phone number and email address
Description, logo and photos
Social media accounts
Creditworthiness or future results

Verification cycles

VRF-BE-2026-000131First verification · Current · 19 Oct 2026 – 19 Oct 2027Verified

03Financials

Five financial years, checked

Every checked amount was compared with the annual accounts filed with the official register. The result label for each year is always public.

Verified
Not disclosed
Not available

USD · financial year = calendar year

Financial results FY 2021 to FY 2025, oldest first. Each value shows its verification state.
Metric	FY 20211 Jan – 31 Dec	FY 20221 Jan – 31 Dec	FY 20231 Jan – 31 Dec	FY 20241 Jan – 31 Dec	FY 20251 Jan – 31 Dec	Trend
Result	Loss	Loss	Loss	Profit	Profit	Profit in 2/5
Revenue	US$17,249,769.96Verified	US$505,333,986.77Verified	US$1,223,492,063.31Verified	US$2,312,947,418.52Verified	US$4,459,763,273.42Verified	+25,754% since 2021
Net resultafter tax	-US$378,406,026.40Verified	-US$500,806,103.39Verified	-US$245,787,553.62Verified	US$296,107,073.60Verified	US$1,620,705,775.78Verified	2021–2025
Equity	US$2,223,177,045.53Verified	US$2,824,030,917.52Verified	US$3,840,896,840.90Verified	US$4,188,754,578.49Verified	US$6,703,659,075.83Verified	+202% since 2021
Gross margin	Not available	Not available	Not available	Not available	Not available	—
EBITDA	US$196,247,370.54Verified	US$230,000,859.16Verified	US$535,565,815.72Verified	US$1,146,535,155.66Verified	US$2,892,808,514.78Verified	+1,374% since 2021
Source	—	—	—	—	—

FY 20251 Jan – 31 Dec

Profit

Revenue: US$4,459,763,273.42Verified
Net result: US$1,620,705,775.78Verified
Equity: US$6,703,659,075.83Verified
Gross margin: Not available
EBITDA: US$2,892,808,514.78Verified

FY 20241 Jan – 31 Dec

Profit

Revenue: US$2,312,947,418.52Verified
Net result: US$296,107,073.60Verified
Equity: US$4,188,754,578.49Verified
Gross margin: Not available
EBITDA: US$1,146,535,155.66Verified

FY 20231 Jan – 31 Dec

Loss

Revenue: US$1,223,492,063.31Verified
Net result: -US$245,787,553.62Verified
Equity: US$3,840,896,840.90Verified
Gross margin: Not available
EBITDA: US$535,565,815.72Verified

FY 20221 Jan – 31 Dec

Loss

Revenue: US$505,333,986.77Verified
Net result: -US$500,806,103.39Verified
Equity: US$2,824,030,917.52Verified
Gross margin: Not available
EBITDA: US$230,000,859.16Verified

FY 20211 Jan – 31 Dec

Loss

Revenue: US$17,249,769.96Verified
Net result: -US$378,406,026.40Verified
Equity: US$2,223,177,045.53Verified
Gross margin: Not available
EBITDA: US$196,247,370.54Verified

Trend over the years

Revenue
+25,754% since 2021
Net result
2021–2025
Equity
+202% since 2021
Gross margin
—
EBITDA
+1,374% since 2021

What the states and labels mean

Profit · Loss · Break-even: Based on the net result of the financial year. Break-even: the net result, positive or negative, is at most 1% of that year's revenue. Otherwise a positive net result is a profit and a negative one a loss. If the year has no revenue figure, it is break-even only when the net result is exactly 0.
Verified: Checked by MeritVeri against the filed annual accounts or other official sources, in a verification that is valid today.
Not disclosed: The company chose not to publish this value.
Not available: There is no value for this financial year.
Amount hidden by the company: The company chose not to show its amounts. The years, the state of each value and the result of each year stay public.

04People

Who runs and owns it

Management, owners and board, checked by MeritVeri against official sources such as the official gazette and filed annual accounts, and against the company's own published annual reports.

Employees: 510.9 employees (FTE) · as of 31 Dec 2025; Verified

Board of directorsChecked 19 Oct 2026

Filip BorgionsDirector · Since 2025
Verified
Arjen LemmenDirector · Since 2025
Verified
Roel LigteringenDirector · Since 2025
Verified

Only people marked “Verified” were checked by MeritVeri in a valid verification. “Checked earlier” means that verification is no longer valid.

If you are listed here and do not want to be shown, let us know and we will hide your name. More in our privacy policy.

05Business details

Business details

Each detail says where it comes from. Only details marked “Verified” were checked by MeritVeri.

Legal name: argenx
Trading name: argenx
Enterprise number: 0818.292.196; Verified
VAT number: BE 0818.292.196; Verified
Registered office: Industriepark-Zwijnaarde 79052 GentBelgium; Verified
Industry: Healthcare
Founded: 2009; Verified
Employees: 510.9 FTEas of 31 Dec 2025; Verified
Website: argenx.com (opens in a new tab); Verified
Social media: LinkedIn (opens in a new tab)

Listing updated on 19 Oct 2026 · Report incorrect information

06Awards

Awards

Results of published award editions. Placements are decided by MeritVeri and can never be bought.

No published award results yet.

About our awards

07Reviews

What people report

Experiences of customers, employees and business relations. Every review is checked by MeritVeri before it is published; the company cannot remove or reorder them.

—

0 published reviews

5 stars: 0 of 0
4 stars: 0 of 0
3 stars: 0 of 0
2 stars: 0 of 0
1 star: 0 of 0

Customers: 0
Employees: 0
Business relations: 0

Write a review

No reviews yet

Have you worked with argenx? Share your experience and help others decide.

Write the first review

Only reviews approved by MeritVeri are shown and counted. How reviews work

Is this your company? Claim this profile

Keep the profile up to date, respond to reviews and apply for verification.

Something wrong in this listing?

Tell us and we will check it. Nothing changes without a person looking at it.